Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.37 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.36 |
| ▸ | PLA2G5 | P39877 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.35 |
| ▸ | RECQL | P46063 | 1/20 | 0.34 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.34 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.34 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | BTK | Q06187 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22128692 | 0.81 | PLA2G10 (0.38) | HRH3PLA2G10PLA2G5KMT2A | |
| SCHEMBL19883851 | 0.80 | HSD17B10 (0.34) | HRH3PLA2G10PLA2G5CHRM2CHRM1 | |
| SCHEMBL13069905 | 0.79 | HRH3 (0.38) | HRH3RECQLHPGDESR2 | |
| SCHEMBL16480466 | 0.79 | HRH3 (0.48) | HRH3KMT2AL3MBTL1CHRM2HPGD | |
| SCHEMBL19060492 | 0.79 | HRH3 (0.48) | HRH3KMT2AL3MBTL1CHRM2HPGD | |
| SCHEMBL22128751 | 0.78 | NR1H2 (0.36) | PLA2G10PLA2G5KMT2AMEN1 | |
| SCHEMBL30115827 | 0.78 | NR1H2 (0.49) | KMT2ARECQLHPGDMEN1 | |
| SCHEMBL24249167 | 0.77 | MAPK1 (0.44) | PLA2G10PLA2G5KMT2AL3MBTL1CHRM2 | |
| SCHEMBL4085410 | 0.76 | ALDH1A1 (0.43) | HRH3KMT2AL3MBTL1CHRM1HPGD | |
| SCHEMBL4085412 | 0.76 | ALDH1A1 (0.43) | HRH3KMT2AL3MBTL1CHRM1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114456103-A | Sulfonylated protein specific marker molecule, and preparation method and application thereof | 中国人民解放军军事科学院军事医学研究院 | 2022-05-10 | — | — | CN | claimed |
| CN-114456103-A | Sulfonylated protein specific marker molecule, and preparation method and application thereof | 中国人民解放军军事科学院军事医学研究院 | 2022-05-10 | — | — | CN | disclosed |
| US-9023656-B2 | Reactive mass labels | ELECTROPHORETICS LIMITED (GB) | 2015-05-05 | — | — | US | disclosed |
| US-9023656-B2 | Reactive mass labels | ELECTROPHORETICS LIMITED (GB) | 2015-05-05 | — | — | US | disclosed |
| US-8697604-B2 | Labeling agents for mass spectrometry comprising tertiary amines | ELECTROPHORETICS LIMITED (GB) | 2014-04-15 | — | — | US | disclosed |
| EP-1606623-B1 | LABELLING AGENTS FOR MASS SPECTROMETRY COMPRISING TERTIARY AMINES | ELECTROPHORETICS LTD (GB) | 2013-05-22 | — | — | EP | disclosed |
| EP-1606623-B1 | LABELLING AGENTS FOR MASS SPECTROMETRY COMPRISING TERTIARY AMINES | ELECTROPHORETICS LTD (GB) | 2013-05-22 | — | — | EP | disclosed |
| EP-1907860-B1 | MASS LABELS | ELECTROPHORETICS LTD (GB) | 2010-11-17 | — | — | EP | disclosed |
| US-20100178710-A1 | Mass Labels | ELECTROPHORETICS LIMITED (GB) | 2010-07-15 | — | — | US | disclosed |
| US-20100178710-A1 | Mass Labels | ELECTROPHORETICS LIMITED (GB) | 2010-07-15 | — | — | US | disclosed |
| CN-101313223-A | Mass labels for biomolecules comprising a 2, 6-dimethyl-piperidin-1-yl-methylene or pyrimidin-2-ylthiomethylene mass label moiety and a succinimidyl-oxy-carbonyl active functional group | ELECTROPHORETICS LTD (GB) | 2008-11-26 | — | — | CN | disclosed |
| WO-2007012849-A2 | MASS LABELS FOR BIOMOLECULES CONTAINING A 2,6-DIMETHYL-PIPERIDIN-l-YL METHYLENE OR A PYRIMIDIN-2-YL THIOMETHYLENE MASS MARKER MOIETY AND A SUCCINIMID-OXY-CARBONYL REACTIVE FUNCTIONAL GROUP | ELECTROPHORETICS LIMITED (GB) | 2007-02-01 | — | — | WO | disclosed |
| US-20070023628-A1 | Labeling agents for mass spectrometry comprising tertiary amines | ELECTROPHORETICS LIMITED (GB) | 2007-02-01 | — | — | US | disclosed |
| US-20070023628-A1 | Labeling agents for mass spectrometry comprising tertiary amines | ELECTROPHORETICS LIMITED (GB) | 2007-02-01 | — | — | US | disclosed |
| US-20070023628-A1 | Labeling agents for mass spectrometry comprising tertiary amines | ELECTROPHORETICS LIMITED (GB) | 2007-02-01 | — | — | US | disclosed |
| EP-1606623-A2 | LABELLING AGENTS FOR MASS SPECTROMETRY COMPRISING TERTIARY AMINES | Xzillion GmbH & CO.KG (DE) | 2005-12-21 | — | — | EP | disclosed |
| WO-2004086050-A2 | LABELLING AGENTS FOR MASS SPECTROMETRY COMPRISING TERTIARY AMINES | XZILLION GMBH & CO. KG (DE) | 2004-10-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100178710-A1 | Mass Labels | B2M, SRRM2, CCNB1 | HRH3 1590/4885PLA2G10 3846/4885PLA2G5 3934/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.